| 000 | 01641 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514053426.0 | ||
| 264 | 0 | _c20030318 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a1533-0028 | ||
| 024 | 7 |
_a10.3816/CCC.2002.n.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Jian-Ming | |
| 245 | 0 | 0 |
_aCombination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevance. _h[electronic resource] |
| 260 |
_bClinical colorectal cancer _cNov 2002 |
||
| 300 |
_a182-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 |
_aThymidylate Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTopoisomerase I Inhibitors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aAzzariti, Amalia | |
| 700 | 1 | _aTommasi, Stefania | |
| 700 | 1 | _aLacalamita, Rosanna | |
| 700 | 1 | _aColucci, Giuseppe | |
| 700 | 1 | _aJohnston, Patrick G | |
| 700 | 1 | _aChurch, Stewart W | |
| 700 | 1 | _aParadiso, Angelo | |
| 773 | 0 |
_tClinical colorectal cancer _gvol. 2 _gno. 3 _gp. 182-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/CCC.2002.n.023 _zAvailable from publisher's website |
| 999 |
_c12286852 _d12286852 |
||